Literature DB >> 23828309

Leflunomide, a valid and safe drug for the treatment of chronic anterior uveitis associated with juvenile idiopathic arthritis.

Clara Molina1, Consuelo Modesto, Nieves Martín-Begué, Cristina Arnal.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23828309     DOI： 10.1007/s10067-013-2315-2

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN： 0770-3198            Impact factor:   2.980


× No keyword cloud information.
  13 in total

Review 1.  Leflunomide: a review of its use in active rheumatoid arthritis.

Authors:  A Prakash; B Jarvis
Journal:  Drugs       Date:  1999-12       Impact factor: 9.546

2.  International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001.

Authors:  Ross E Petty; Taunton R Southwood; Prudence Manners; John Baum; David N Glass; Jose Goldenberg; Xiaohu He; Jose Maldonado-Cocco; Javier Orozco-Alcala; Anne-Marie Prieur; Maria E Suarez-Almazor; Patricia Woo
Journal:  J Rheumatol       Date:  2004-02       Impact factor: 4.666

3.  Outcomes of treatment with immunomodulatory therapy in patients with corticosteroid-resistant juvenile idiopathic arthritis-associated chronic iridocyclitis.

Authors:  Ellen N Yu; Margherita E Meniconi; Fehma Tufail; Stefanos Baltatzis; C Stephen Foster
Journal:  Ocul Immunol Inflamm       Date:  2005 Sep-Oct       Impact factor: 3.070

4.  Visual outcomes prognosticators in juvenile rheumatoid arthritis-associated uveitis.

Authors:  M R Dana; J Merayo-Lloves; D A Schaumberg; C S Foster
Journal:  Ophthalmology       Date:  1997-02       Impact factor: 12.079

5.  Leflunomide or methotrexate for juvenile rheumatoid arthritis.

Authors:  Earl Silverman; Richard Mouy; Lynn Spiegel; Lawrence K Jung; Rotraud K Saurenmann; Pekka Lahdenne; Gerd Horneff; Immaculada Calvo; Ilona S Szer; Karen Simpson; John A Stewart; Vibeke Strand
Journal:  N Engl J Med       Date:  2005-04-21       Impact factor: 91.245

Review 6.  Current therapeutic approaches to autoimmune chronic uveitis in children.

Authors:  Gabriele Simonini; Luca Cantarini; Cecilia Bresci; Monica Lorusso; Mauro Galeazzi; Rolando Cimaz
Journal:  Autoimmun Rev       Date:  2010-05-26       Impact factor: 9.754

7.  Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.

Authors:  Ivan Foeldvari; Angela Wierk
Journal:  J Rheumatol       Date:  2005-02       Impact factor: 4.666

8.  Course, complications, and outcome of juvenile arthritis-related uveitis.

Authors:  Kourosh Sabri; Rotraud K Saurenmann; Earl D Silverman; Alex V Levin
Journal:  J AAPOS       Date:  2008-09-12       Impact factor: 1.220

9.  Methotrexate for uveitis associated with juvenile idiopathic arthritis: value and requirement for additional anti-inflammatory medication.

Authors:  A Heiligenhaus; A Mingels; C Heinz; G Ganser
Journal:  Eur J Ophthalmol       Date:  2007 Sep-Oct       Impact factor: 2.597

Review 10.  Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop.

Authors:  Douglas A Jabs; Robert B Nussenblatt; James T Rosenbaum
Journal:  Am J Ophthalmol       Date:  2005-09       Impact factor: 5.258
View more
  8 in total

Review 1.  The Future Is Now: Biologics for Non-Infectious Pediatric Anterior Uveitis.

Authors:  Melissa A Lerman; C Egla Rabinovich
Journal:  Paediatr Drugs       Date:  2015-08       Impact factor: 3.022

2.  [Intermediate uveitis: guidelines of the German Ophthalmological Society and the Professional Association of German Ophthalmologists].

Authors:  F Mackensen; L Baydoun; J Garweg; A Heiligenhaus; T Hudde
Journal:  Ophthalmologe       Date:  2014-11       Impact factor: 1.059

Review 3.  [Guidelines nr. 24a intermediate uveitis].

Authors: 
Journal:  Ophthalmologe       Date:  2021-01       Impact factor: 1.059

Review 4.  Treatment of uveitis associated with juvenile idiopathic arthritis.

Authors:  Rosa Bou; Estíbaliz Iglesias; Jordi Antón
Journal:  Curr Rheumatol Rep       Date:  2014-08       Impact factor: 4.592

Review 5.  Systemic treatments for noninfectious vitreous inflammation.

Authors:  Angela Jiang; Jillian Wang; Malav Joshi; John Byron Christoforidis
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

6.  Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry.

Authors:  Lauren A Henderson; David Zurakowski; Sheila T Angeles-Han; Andrew Lasky; C Egla Rabinovich; Mindy S Lo
Journal:  Pediatr Rheumatol Online J       Date:  2016-02-16       Impact factor: 3.054

7.  Consensus-based recommendations for the management of uveitis associated with juvenile idiopathic arthritis: the SHARE initiative.

Authors:  Tamas Constantin; Ivan Foeldvari; Jordi Anton; Joke de Boer; Severine Czitrom-Guillaume; Clive Edelsten; Raz Gepstein; Arnd Heiligenhaus; Clarissa A Pilkington; Gabriele Simonini; Yosef Uziel; Sebastian J Vastert; Nico M Wulffraat; Anne-Mieke Haasnoot; Karoline Walscheid; Annamária Pálinkás; Reshma Pattani; Zoltán Györgyi; Richárd Kozma; Victor Boom; Andrea Ponyi; Angelo Ravelli; Athimalaipet V Ramanan
Journal:  Ann Rheum Dis       Date:  2018-03-28       Impact factor: 19.103

8.  Leflunomide treatment in juvenile idiopathic arthritis.

Authors:  Nuray Aktay Ayaz; Şerife Gül Karadağ; Figen Çakmak; Mustafa Çakan; Ayşe Tanatar; Hafize Emine Sönmez
Journal:  Rheumatol Int       Date:  2019-07-20       Impact factor: 2.631
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.